Trials / Completed
CompletedNCT06240442
Bodyweight Interval Exercise in the Fed Versus Fasted State
Bodyweight Interval Exercise in the Fed Versus Fasted State on Postprandial Glycemia, Appetite Perceptions and Fat Oxidation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Toronto · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effects of a single session of at-home bodyweight interval exercise, performed in the fasted or fed state, on postprandial glycemic management, post-exercise fat oxidation, and overall perceptions of appetite in recreationally active females. This is a remote/online study and does not involve any visits to the laboratory.
Detailed description
Following the acquisition of informed consent via videoconferencing, eligibility to participate in the study will be determined using questionnaires. If inclusion criteria is met, participants will undergo virtual exercise familiarization by following a pre-recorded instructional video. Eligible participants will be assigned, in a random order, to two metabolic trials at least 3 days apart in the follicular phase of the same menstrual cycle. These visits will be online with an investigator on videoconferencing. The two trials involve: 1) Exercise followed by breakfast; and 2) Breakfast followed by exercise. Various outcomes will be measured throughout the metabolic trials including: blood sugar, fat oxidation and appetite. All research tools needed to acquire these methods will be delivered to participants' place of residence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fasted exercise | Bodyweight interval exercise performed 5 minutes before the start of a mixed-macronutrient breakfast meal |
| OTHER | Fed exercise | Bodyweight interval exercise performed 10 minutes after the start of consuming a mixed-macronutrient breakfast meal |
Timeline
- Start date
- 2021-05-14
- Primary completion
- 2021-08-30
- Completion
- 2021-08-30
- First posted
- 2024-02-05
- Last updated
- 2024-02-05
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06240442. Inclusion in this directory is not an endorsement.